Heat-stable measles vaccine produced by spray drying (Q43234482)

16 November 2017

Heat-stable measles vaccine produced by spray drying (English)

1 reference

16 November 2017

1 reference

1 reference

Satoshi Ohtake

1

1 reference

16 November 2017

Russell A Martin

2

1 reference

16 November 2017

Luisa Yee

3

1 reference

16 November 2017

Dexiang Chen

4

1 reference

16 November 2017

Debra D Kristensen

5

1 reference

16 November 2017

David Lechuga-Ballesteros

6

1 reference

16 November 2017

Vu Truong-Le

7

1 reference

16 November 2017

language of work or name

English

0 references

publication date

25 November 2009

1 reference

16 November 2017

1 reference

16 November 2017

28

1 reference

16 November 2017

5

1 reference

16 November 2017

1275-1284

1 reference

Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric beta-galactosidase

16 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Decreased protein-stabilizing effects of cryoprotectants due to crystallization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Phase separation of excipients during lyophilization: effects on protein stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

The effect of stabilizers and denaturants on the cold denaturation temperatures of proteins and implications for freeze-drying

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Surface-induced denaturation of proteins during freezing and its inhibition by surfactants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzyme activity and calorimetric studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Pharmaceutical particle engineering via spray drying

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Feasibility study on spray-drying protein pharmaceuticals: recombinant human growth hormone and tissue-type plasminogen activator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Buccal transmucosal delivery of calcitonin in rabbits using thin-film composites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Mass vaccination: solutions in the skin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Targeting of drugs and vaccines to the gut.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: a double-blind, randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Effect of freezing rates and excipients on the infectivity of a live viral vaccine during lyophilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Preservation of membranes in anhydrobiotic organisms: the role of trehalose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Effects of vitrified and nonvitrified sugars on phosphatidylcholine fluid-to-gel phase transitions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Fast dynamics and stabilization of proteins: binary glasses of trehalose and glycerol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Stability and surface activity of lactate dehydrogenase in spray-dried trehalose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

The influence of divalent cations on the stability of human rotavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Adeno-associated virus vectors show variable dependence on divalent cations for thermostability: implications for purification and handling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

A zinc ion controls assembly and stability of the major capsid protein of rotavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Effect of pH, counter ion, and phosphate concentration on the glass transition temperature of freeze-dried sugar-phosphate mixtures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Solubilization and reconstitution of vesicular stomatitis virus envelope using octylglucoside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Effect of initial buffer composition on pH changes during far-from-equilibrium freezing of sodium phosphate buffer solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Observations on drying bacteria from the frozen and from the liquid state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Recoveries of bacteria after drying and heating in glutamate foams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Spray-drying of air-liquid interface sensitive recombinant human growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Inertial suppression of protein dynamics in a binary glycerol-trehalose glass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Is arginine a protein-denaturant?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Biotechnology applications of amino acids in protein purification and formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Arginine facilitates inactivation of enveloped viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Co-operative thermal inactivation of herpes simplex virus and influenza virus by arginine and NaCl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Synergistic virus inactivation effects of arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Stabilization of measles virus for vaccine formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Effects of bovine somatotropin (rbSt) concentration at different moisture levels on the physical stability of sucrose in freeze-dried rbSt/sucrose mixtures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Intracellular trehalose improves the survival of cryopreserved mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Preservation of freeze-dried liposomes by trehalose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

Intracellular delivery of trehalose into mammalian cells by electropermeabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.024

10.1016/J.VACCINE.2009.11.024

7 January 2021

Identifiers

DOI

1 reference

16 November 2017

1 reference